The average of price targets set by Wall Street analysts indicates a potential upside of 25.6% in BioNTech (BNTX). While the effectiveness of this highly sought-after metric is questionable, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback